Table 4. Relationship between EV-protein level and heart failure with reduced ejection fraction (HFREF) compared to heart failure with preserved ejection fraction (HFPEF).
| Multivariable analysis | HFREF vs. HFPEF | ||
|---|---|---|---|
| OR | p-value | 95%CI | |
| Cystatin C | |||
| TEX | 1.15 | 0.830 | (0.32–4.12) |
| LDL | 1.29 | 0.748 | (0.27–6.11) |
| HDL | 1.55 | 0.501 | (0.43–5.58) |
| CD14 | |||
| TEX | 0.39 | 0.088 | (0.14–1.15) |
| LDL | 0.29 | 0.062 | (0.08–1.07) |
| HDL | 0.65 | 0.412 | (0.24–1.80) |
| Serpin F2 | |||
| TEX | 0.70 | 0.453 | (0.28–1.76) |
| LDL | 0.60 | 0.223 | (0.26–1.37) |
| HDL | 0.42 | 0.048 | (0.18–0.99) |
| Serpin G1 | |||
| TEX | 1.96 | 0.414 | (0.39–9.91) |
| LDL | 2.66 | 0.410 | (0.26–27.18) |
| HDL | 1.76 | 0.359 | (0.52–5.94) |
Adjustment for confounders (age, gender, hypertension, diabetes, anemia and chronic renal impairment). OR = odds ratio.